Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib Monotherapy in Refractory HER2+ Metastatic Breast Cancer
NCT00062686Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by GSK. Started Nov 2003; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00062686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062686.